Literature DB >> 6190550

Pituitary adenomas. Immunocytochemical study of 150 tumors with clinicopathologic correlation.

K Mukai.   

Abstract

Retrospective immunocytochemical study of prolactin, growth hormone, ACTH, TSH and gonadotropins was performed on 150 pituitary adenomas from 142 patients and the results were correlated with clinical manifestations. There were 60 prolactin-positive tumors, 13 growth hormone-positive tumors, nine ACTH-positive tumors and seven gonadotropin-positive tumors. Seven tumors showed positivity for both prolactin and growth hormone, one tumor was positive for prolactin and ACTH and another was positive for prolactin and TSH. Fifty-two tumors were negative for all the hormones. In the hormone secreting tumors, the results of immunocytochemical study correlated very well with clinical manifestations, while most of the hormone-negative tumors were nonfunctioning clinically. This study demonstrates the reliability of the immunocytochemical method in clinicopathologic study of pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190550     DOI: 10.1002/1097-0142(19830815)52:4<648::aid-cncr2820520414>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

2.  Immunohistochemical colocalization of growth hormone (GH) and alpha subunit in human GH secreting pituitary adenomas.

Authors:  R Y Osamura; K Watanabe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

Review 3.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Electron microscopical morphometry of GH producing pituitary adenomas in comparison with normal GH cells.

Authors:  W Saeger; K Rübenach-Gerz; J Caselitz; D K Lüdecke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Pituitary adenomas in patients under 20 years old. A clinicopathological study of 12 cases.

Authors:  K Mukai; E L Seljeskog; L P Dehner
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

6.  ASSESSMENT AND COMPARISON OF HORMONAL IMMUNOEXPRESSION AND THE CLINICAL PICTURE IN PATIENTS WITH PITUITARY ADENOMAS.

Authors:  B Kwinta; A Myszka; R M Krzyżewski; K M Kliś; M R Dragan; D Adamek
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

7.  Immunohistochemistry as a predictor of clinical outcome in patients given postoperative radiation for subtotally resected pituitary adenomas.

Authors:  J J Kovalic; G Mazoujian; D W McKeel; B B Fineberg; P W Grigsby
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

8.  Immunohistochemical Heterogeneity Within Clinically Nonfunctioning Pituitary Adenomas.

Authors:  Shozo Yamada; Toshiaki Sano; Michie Takahashi; Yoshimasa Shishiba; Akira Teramoto
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

9.  Incidence, Pathology, and Recurrence of Pituitary Adenomas: Study of 647 Unselected Surgical Cases.

Authors:  Takahiko Terada; Kalman Kovacs; Lucia Stefaneanu; Eva Horvath
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

Review 10.  Multiple endocrine neoplasia type 1 (MEN 1) revisited.

Authors:  B Padberg; S Schröder; C Capella; A Frilling; G Klöppel; P U Heitz
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.